Literature DB >> 17767354

Cytokine-leukotriene receptor interactions.

Marek Rola-Pleszczynski1, Jana Stankova.   

Abstract

Biochemical and pharmacological studies have identified the structure of leukotrienes, the pathways that lead to their synthesis, and the signaling events they trigger when they interact with their cognate receptors. A privileged interaction exists between these lipid mediators and another group of molecules essential for inflammation and immune modulation, namely, cytokines. Whereas leukotrienes can trigger the synthesis and release of selected cytokines in distinct cell populations, many cytokines can affect cellular responsiveness to leukotrienes by modulating leukotriene receptor expression. As we progressively begin to unravel these complex interactions, new areas of cell-cell communication and eventual therapeutic interventions will emerge.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17767354      PMCID: PMC5901110          DOI: 10.1100/tsw.2007.183

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  3 in total

1.  Leukotriene inhibitors with dexamethasone show promise in the prevention of death in COVID-19 patients with low oxygen saturations.

Authors:  Peter L Elkin; Skyler Resendez; Sarah Mullin; Bruce R Troen; Manoj J Mammen; Shirley Chang; Gillian Franklin; Wilmon McCray; Steven H Brown
Journal:  J Clin Transl Sci       Date:  2022-05-16

2.  Comparative analysis of inflammatory gene expression levels in metabolic syndrome & coronary artery disease.

Authors:  Jiny Nair; Vijay V Kakkar; Jayashree Shanker
Journal:  Indian J Med Res       Date:  2017-06       Impact factor: 2.375

3.  Leukotriene D4 and interleukin-13 cooperate to increase the release of eotaxin-3 by airway epithelial cells.

Authors:  Véronique Provost; Anick Langlois; François Chouinard; Marek Rola-Pleszczynski; Jamila Chakir; Nicolas Flamand; Michel Laviolette
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.